Search Count: 80
![]() |
Co-Structure Of Sars-Cov-2 3C-Like Proteinase Nsp5 With Compound 34
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.87 Å Release Date: 2026-03-04 Classification: HYDROLASE Ligands: A1CAR |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-03-04
Ligands: A1CAR
![]() |
Co-Structure Of Main Protease Of Sars-Cov-2 With Compound 1
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2026-02-18 Classification: HYDROLASE Ligands: A1CAS, NA |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-02-18
Ligands: A1CAS, NA
![]() |
Co-Structure Of Main Protease Of Sars-Cov-2 With Compound 11
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.46 Å Release Date: 2026-02-18 Classification: HYDROLASE Ligands: A1CBN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-02-18
Ligands: A1CBN
![]() |
Co-Structure Of Main Protease Of Sars-Cov-2 With Compound 2
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2026-02-18 Classification: HYDROLASE Ligands: A1CBY |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-02-18
Ligands: A1CBY
![]() |
Co-Structure Of Main Protease Of Sars-Cov-2 With Compound 10
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.71 Å Release Date: 2026-02-18 Classification: HYDROLASE Ligands: A1CB2 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-02-18
Ligands: A1CB2
![]() |
Co-Structure Of Main Protease Of Sars-Cov-2 With Nvp-Egt710
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.87 Å Release Date: 2025-12-24 Classification: HYDROLASE Ligands: A1CBU |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-24
Ligands: A1CBU
![]() |
Mers Mpro With Egt710
Organism: Middle east respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION Resolution:3.04 Å Release Date: 2025-12-24 Classification: HYDROLASE Ligands: A1CBU |
Organism: Middle east respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2025-12-24
Ligands: A1CBU
![]() |
Oc43 Mpro With Egt710
Organism: Human coronavirus oc43
Method: X-RAY DIFFRACTION Resolution:2.12 Å Release Date: 2025-12-24 Classification: HYDROLASE Ligands: A1CBU |
Organism: Human coronavirus oc43
Method: X-RAY DIFFRACTION
Release Date: 2025-12-24
Ligands: A1CBU
![]() |
Crystal Structure Of Sars-Cov-2 Mpro S10A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: V2M
![]() |
Crystal Structure Of Sars-Cov-2 Mpro S10C In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: DMS, EDO, V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: DMS, EDO, V2M
![]() |
Crystal Structure Of Sars-Cov-2 Mpro S113A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: V2M
![]() |
Crystal Structure Of Sars-Cov-2 Mpro S113C In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.28 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: V2M
![]() |
Crystal Structure Of Sars-Cov-2 Mpro L115A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: V2M
![]() |
Crystal Structure Of Sars-Cov-2 Mpro L115M In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.19 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: V2M
![]() |
Crystal Structure Of Sars-Cov-2 Mpro S147A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.13 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: V2M
![]() |
Crystal Structure Of Sars-Cov-2 Mpro S147N In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: V2M
![]() |
Co-Crystal Structure Of Feline Coronavirus Uu23 Main Protease With Nirmatrelvir
Organism: Feline coronavirus uu23
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2025-11-26 Classification: VIRAL PROTEIN Ligands: 4WI, PEG |
Organism: Feline coronavirus uu23
Method: X-RAY DIFFRACTION
Release Date: 2025-11-26
Ligands: 4WI, PEG
![]() |
Co-Crystal Structure Of Feline Coronavirus Uu23 Main Protease With Gc376
Organism: Feline coronavirus uu23
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2025-11-26 Classification: VIRAL PROTEIN Ligands: B1S |
Organism: Feline coronavirus uu23
Method: X-RAY DIFFRACTION
Release Date: 2025-11-26
Ligands: B1S
![]() |
Co-Crystal Structure Of Feline Coronavirus Uu23 Main Protease With Pfizer Intravenous Compound Pf-00835231
Organism: Feline alphacoronavirus 1
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2025-11-26 Classification: VIRAL PROTEIN Ligands: V2M, ACY, PG4, EDO, PEG |
Organism: Feline alphacoronavirus 1
Method: X-RAY DIFFRACTION
Release Date: 2025-11-26
Ligands: V2M, ACY, PG4, EDO, PEG
![]() |
Co-Crystal Structure Of Feline Coronavirus Uu23 Main Protease With Ibuzatrelvir
Organism: Feline coronavirus uu23
Method: X-RAY DIFFRACTION Resolution:2.27 Å Release Date: 2025-11-26 Classification: VIRAL PROTEIN Ligands: YDL |
Organism: Feline coronavirus uu23
Method: X-RAY DIFFRACTION
Release Date: 2025-11-26
Ligands: YDL
